Leucovorin calcium and Novolog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Leucovorin calcium (leucovorin calcium) and Novolog (insulin aspart recombinant). Common drug interactions include haemorrhagic anaemia among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Leucovorin calcium and Novolog. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Leucovorin calcium?

Leucovorin calcium has active ingredients of leucovorin calcium. It is often used in rheumatoid arthritis. eHealthMe is studying from 24,650 Leucovorin calcium users. Check the latest studies of Leucovorin calcium.

What is Novolog?

Novolog has active ingredients of insulin aspart recombinant. It is often used in diabetes. eHealthMe is studying from 56,160 Novolog users. Check the latest studies of Novolog.



On Jul, 09, 2026

32 people who take Leucovorin calcium and Novolog together, and have interactions are studied.

Leucovorin calcium and Novolog drug interactions.

What are the common drug interactions of Leucovorin Calcium and Novolog, by gender? *:

female:

  1. Haemorrhagic anaemia (anaemia due to excessive bleeding)
  2. Heart rate increased
  3. Hypokalaemia (low potassium)
  4. Infection
  5. Melaena (the passage of black, tarry stools)
  6. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  7. Multiple injuries
  8. Rash
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Staphylococcal infection (an infection with staphylococcus bacteria)

male:

  1. Diarrhoea
  2. Pyrexia (fever)
  3. Angina pectoris (chest pain due to ischemia of the heart muscle)
  4. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  5. Blood bicarbonate decreased
  6. Blood chloride increased
  7. Blood creatinine increased
  8. Blood phosphorus decreased
  9. Chills (felling of cold)
  10. Confusional state

What are the common drug interactions of Leucovorin Calcium and Novolog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood pressure increased
  2. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  3. Eye pain
  4. Fall
  5. Headache (pain in head)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Influenza like illness
  8. Infusion site infection
  9. Localised infection (infection at the single location)
  10. Oral candidiasis (fungal infection of mouth)

50-59:

  1. Colorectal cancer (colon cancer or bowel cancer)
  2. Drug effect decreased
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  4. Urinary incontinence (inability to control the flow of urine and involuntary urination)

60+:

  1. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  2. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  3. Bradycardia (abnormally slow heart action)
  4. Chest discomfort
  5. Dehydration (dryness resulting from the removal of water)
  6. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  7. Dyspnoea (difficult or laboured respiration)
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Haematocrit decreased
  10. Haemoglobin decreased

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 6 people, 18.75%
  2. Colon Cancer: 6 people, 18.75%
  3. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 4 people, 12.50%
  4. Cardiac Failure Congestive: 3 people, 9.38%
  5. Rectal Cancer (cancer of rectum): 2 people, 6.25%
  6. Neoplasm Malignant (cancer tumour): 2 people, 6.25%
  7. Hypersensitivity: 2 people, 6.25%
  8. High Blood Cholesterol: 2 people, 6.25%
  9. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Leucovorin calcium and Novolog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Leucovorin calcium and Novolog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Leucovorin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Novolog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Leucovorin calcium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Novolog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on leucovorin calcium and insulin aspart recombinant (the active ingredients of Leucovorin calcium and Novolog, respectively), and Leucovorin calcium and Novolog (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: